Established capsid and peptide ELISA as well as Transduction Inhibition Assays (TIAs) for different AAV serotypes relevant for gene therapy for haemophilia
High prevalence of total and neutralizing AAV antibodies found among Indian population
The AAV antibody prevalence between healthy population and individuals with haemophilia A
or B were similar
